Correlation Between Genscript Biotech and Crinetics Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Genscript Biotech and Crinetics Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Genscript Biotech and Crinetics Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Genscript Biotech and Crinetics Pharmaceuticals, you can compare the effects of market volatilities on Genscript Biotech and Crinetics Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Genscript Biotech with a short position of Crinetics Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Genscript Biotech and Crinetics Pharmaceuticals.
Diversification Opportunities for Genscript Biotech and Crinetics Pharmaceuticals
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Genscript and Crinetics is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Genscript Biotech and Crinetics Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Crinetics Pharmaceuticals and Genscript Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Genscript Biotech are associated (or correlated) with Crinetics Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Crinetics Pharmaceuticals has no effect on the direction of Genscript Biotech i.e., Genscript Biotech and Crinetics Pharmaceuticals go up and down completely randomly.
Pair Corralation between Genscript Biotech and Crinetics Pharmaceuticals
Assuming the 90 days horizon Genscript Biotech is expected to under-perform the Crinetics Pharmaceuticals. But the pink sheet apears to be less risky and, when comparing its historical volatility, Genscript Biotech is 1.16 times less risky than Crinetics Pharmaceuticals. The pink sheet trades about -0.02 of its potential returns per unit of risk. The Crinetics Pharmaceuticals is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest 2,203 in Crinetics Pharmaceuticals on August 29, 2024 and sell it today you would earn a total of 3,474 from holding Crinetics Pharmaceuticals or generate 157.69% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Genscript Biotech vs. Crinetics Pharmaceuticals
Performance |
| Timeline |
| Genscript Biotech |
| Crinetics Pharmaceuticals |
Genscript Biotech and Crinetics Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Genscript Biotech and Crinetics Pharmaceuticals
The main advantage of trading using opposite Genscript Biotech and Crinetics Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Genscript Biotech position performs unexpectedly, Crinetics Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Crinetics Pharmaceuticals will offset losses from the drop in Crinetics Pharmaceuticals' long position.| Genscript Biotech vs. Telix Pharmaceuticals Limited | Genscript Biotech vs. Keros Therapeutics | Genscript Biotech vs. Zentalis Pharmaceuticals Llc | Genscript Biotech vs. Innovent Biologics |
| Crinetics Pharmaceuticals vs. Eliem Therapeutics | Crinetics Pharmaceuticals vs. Scpharmaceuticals | Crinetics Pharmaceuticals vs. Milestone Pharmaceuticals | Crinetics Pharmaceuticals vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |